Recombinant pig cutaneous repair substance (rrhEGF) is demonstrating increased recognition as a promising strategy in the area of wound medicine. This bioactive compound, produced through genetic engineering, delivers https://recombinantporcineegf177248.newsyblog.com/1167742/engineered-porcine-cutaneous-growth-substance-a-significant-agent-for-tissue-healing